1. Aggressive Differentiated Thyroid Cancer due to EML4e13-ALKe20 Fusion: A Case Presentation and Review of the Literature
   Rodhan Khthir et al, 2021, Case Reports in Endocrinology CrossRef
2. Anaplastic lymphoma kinase-special immunity and immunotherapy
   Ye Guo et al, 2022, Frontiers in Immunology CrossRef
3. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib
   Weifeng Liu et al, 2021, Investigational New Drugs CrossRef
4. Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
   Kamya Sankar et al, 2021, Cancers CrossRef
5. Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib
   Shubin W. Shahab et al, 2023, Frontiers in Oncology CrossRef
6. A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan
   Hsiang-Sheng Wang et al, 2022, International Journal of Molecular Sciences CrossRef
7. Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis
   Puyuan Xing et al, 2022, Frontiers in Oncology CrossRef
8. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells
   Elnaz Salmani-Javan et al, 2023, Frontiers in Oncology CrossRef
9. Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review
   Giovanni Maria Iannantuono et al, 2022, International Journal of Molecular Sciences CrossRef
10. ALK-mutated thyroid cancer
    R. V. Orlova et al, 2024, Clinical Case in Oncology CrossRef
11. New Proteins Contributing to Immune Cell Infiltration and Pannus Formation of Synovial Membrane from Arthritis Diseases
    Dominique de Seny et al, 2021, International Journal of Molecular Sciences CrossRef
12. Cutaneous inflammatory myofibroblastic tumor with CARS‐ALK fusion: Case report and literature review
    Kasey J. McCollum et al, 2022, Journal of Cutaneous Pathology CrossRef
13. Pediatric Non-Myofibroblastic Primitive Spindle Cell Tumors with ALK Gene Rearrangements and Response to Crizotinib
    Dinesh Rakheja et al, 2022, International Journal of Surgical Pathology CrossRef
14. ALK-rearranged renal cell carcinoma—different morphological faces of a rare tumor
    Niels J. Rupp et al, 2020, Virchows Archiv CrossRef
15. Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma
    Kyaw Zwar Myint et al, 2023, Frontiers in Oncology CrossRef
16. Current status and challenges of immunotherapy in ALK rearranged NSCLC
    Rongbin Qi et al, 2022, Frontiers in Oncology CrossRef
17. The role of molecular testing in thyroid tumors
    Vera A. Kachko et al, 2020, Problems of Endocrinology CrossRef
18. Comparison of Efficacy and Safety of Brigatinib in First-Line Treatments for Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Systematic Review and Indirect Treatment Comparison
    Yongfeng Yu et al, 2022, Journal of Clinical Medicine CrossRef